John Friend
Directeur Général chez KAZIA THERAPEUTICS LIMITED
Profil
John E.
Friend is currently the Chief Executive Officer at Kazia Therapeutics Ltd.
Prior to his current position, he served as the Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
He then worked as the Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018, and again from 2020 to 2021.
Additionally, he held the position of Chief Medical Officer at Druggability Technologies Holdings Ltd.
(New Jersey).
Dr. Friend obtained his undergraduate degree from Southern Methodist University and his doctorate from Robert Wood Johnson Medical School.
Postes actifs de John Friend
| Sociétés | Poste | Début |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Directeur Général | 01/05/2023 |
Anciens postes connus de John Friend
| Sociétés | Poste | Fin |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 02/11/2021 |
| CELLECTAR BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 27/11/2018 |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Directeur Technique/Scientifique/R&D | 01/04/2017 |
| Druggability Technologies Holdings Ltd. (New Jersey) | Directeur Technique/Scientifique/R&D | - |
Formation de John Friend
| Southern Methodist University | Undergraduate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Health Technology |
| Druggability Technologies Holdings Ltd. (New Jersey) |